We are delighted to host an insightful ATTC network webinar this November 2026.
As CAR-T use continues to expand, NHS centres face growing pressure on inpatient capacity while seeking to improve patient experience and deliver more care closer to home. Ambulatory CAR-T has the potential to help address these challenges, but its wider adoption requires safe, consistent and sustainable implementation.
Join our NHS experts and patient representative for an early look at the findings of a forthcoming white paper from the ATTC network and Cell and Gene Therapy Catapult, with the support of our industry partners. The session will explore lessons from emerging ambulatory CAR-T programmes and discuss what is needed to support wider adoption across the NHS, from patient safety and monitoring to workforce, infrastructure and national standardisation.
AGENDA
16:00 – 16:10 | Welcome & overview
16:10 – 16:45 | Panel discussion
Chair: Paul Ferguson, Consultant Haematologist, University Hospitals Birmingham NHS Foundation Trust & Co-Director of the MW-ATTC
Panellists:
Jonny Carmichael, Consultant Haematologist, Leeds Teaching Hospitals NHS Trust
Sandra Leadley-Watkins, Patient Representative with Lived Experience
Raakhee Shah, Lead Pharmacist, University College London Hospitals NHS Foundation Trust
Robert Lown, Consultant Haematologist, University Hospital Southampton NHS Trust
Jason Domingo, Advanced Therapies Research Lead Nurse, Cambridge University Hospitals NHS Trust
16:45 – 16:55 | Audience Q&A
16:55 – 17:00 | Closing remarks
Who should attend?
Healthcare professionals, NHS leaders, commissioners, patient organisations, industry representatives and others involved in the delivery and development of CAR-T and other advanced treatments across the UK.